Young employees and scientific and technological personnel are the hope of the future of the enterprise. Group companies carry out discussions and exchanges.
Release time:
2023-01-29
News from our newspaper 1# March 10 , the group company held a symposium for scientific and technological personnel and a symposium for young employees. Nearly 60 representatives from various subsidiaries shared last year's work experience and insights, and put forward their own views on the problems encountered in the work. Group company leaders Jiang Xiaomeng, Xiang Chongping, Lan Xiaolong, Qin Xuping, and Shi Fu attended the meeting and listened carefully to the opinions and suggestions put forward by the representatives.
The speeches of the delegates at this symposium showed their satisfaction with the working atmosphere and system standardization of the peak family. They also put forward their own opinions on the imperfections of the system and the inadequate implementation observed in their daily work, and gave preliminary solutions. Due to the special circumstances of 2022 , the number of collective training and study trips organized by various enterprises has decreased compared with previous years, and the number of suggestions made by employee representatives on study and training has increased significantly. In addition, the representatives also gave feedback on the needs of employee benefits and office equipment.
The opinions and suggestions collected at the symposium will be fed back to relevant departments in different categories. After analysis and discussion, they will be solved one by one. In the future, the group company will continue to unblock feedback channels and systematically consider the demands of employees, so as to improve the management system, optimize the system process, and deepen the understanding of the grassroots, so as to achieve more accurate and efficient management.
Jiang Xiaomeng sent a message to scientific and technical personnel: The group company has always attached great importance to scientific research and innovation, and hopes that scientific and technical personnel will make active efforts to make progress or even leap in various technical indicators, and reduce costs, improve quality, and increase benefits through technological innovation., To establish the company's comparative advantage in the market. For young employees, Jiang Xiaomeng hopes that they will show vigor, vitality and passion in their respective work, do not fear or shrink back when encountering difficulties, have the courage to take responsibility, and regard difficulties as a good opportunity to exercise and improve themselves. Young employees and scientific and technological personnel are the future and hope of the enterprise, and the driving force for the sustainable development and long-term survival of the enterprise. I hope that young employees and scientific and technological personnel will work hard and achieve different results in their posts.
(ReporterChen Shengmu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page